chr11-59843948-GATTC-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_005142.3(CBLIF):βc.183_186delβ(p.Met61IlefsTer8) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000477 in 1,613,614 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (β β ). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: π 0.00023 ( 0 hom., cov: 32)
Exomes π: 0.000029 ( 0 hom. )
Consequence
CBLIF
NM_005142.3 frameshift
NM_005142.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.14
Genes affected
CBLIF (HGNC:4268): (cobalamin binding intrinsic factor) This gene is a member of the cobalamin transport protein family. It encodes a glycoprotein secreted by parietal cells of the gastric mucosa and is required for adequate absorption of vitamin B12. Vitamin B12 is necessary for erythrocyte maturation and mutations in this gene may lead to congenital pernicious anemia. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 11-59843948-GATTC-G is Pathogenic according to our data. Variant chr11-59843948-GATTC-G is described in ClinVar as [Pathogenic]. Clinvar id is 566919.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CBLIF | NM_005142.3 | c.183_186del | p.Met61IlefsTer8 | frameshift_variant | 2/9 | ENST00000257248.3 | NP_005133.2 | |
CBLIF | XM_011544939.4 | c.183_186del | p.Met61IlefsTer8 | frameshift_variant | 2/9 | XP_011543241.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CBLIF | ENST00000257248.3 | c.183_186del | p.Met61IlefsTer8 | frameshift_variant | 2/9 | 1 | NM_005142.3 | ENSP00000257248 | P1 | |
CBLIF | ENST00000532070.1 | n.229_232del | non_coding_transcript_exon_variant | 2/3 | 2 | |||||
CBLIF | ENST00000525058.5 | c.*150_*153del | 3_prime_UTR_variant, NMD_transcript_variant | 2/9 | 2 | ENSP00000433196 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152134Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
35
AN:
152134
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000478 AC: 12AN: 251258Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135782
GnomAD3 exomes
AF:
AC:
12
AN:
251258
Hom.:
AF XY:
AC XY:
6
AN XY:
135782
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461362Hom.: 0 AF XY: 0.0000206 AC XY: 15AN XY: 727012
GnomAD4 exome
AF:
AC:
42
AN:
1461362
Hom.:
AF XY:
AC XY:
15
AN XY:
727012
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000230 AC: 35AN: 152252Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74450
GnomAD4 genome
AF:
AC:
35
AN:
152252
Hom.:
Cov.:
32
AF XY:
AC XY:
18
AN XY:
74450
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hereditary intrinsic factor deficiency Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein | Apr 05, 2023 | ACMG classification criteria: PVS1 very strong, PM2 supporting, PM3 moderated, PP4 - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 12, 2024 | This sequence change creates a premature translational stop signal (p.Met61Ilefs*8) in the GIF gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GIF are known to be pathogenic (PMID: 14576042, 22929189). This variant is present in population databases (rs765896727, gnomAD 0.06%). This premature translational stop signal has been observed in individuals with intrinsic factor deficiency (PMID: 14576042, 19036097, 22854512, 22929189). ClinVar contains an entry for this variant (Variation ID: 566919). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 15, 2005 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Sep 08, 2017 | The c.183_186delGAAT; p.Met61fs was found homozygote in an 11 year old African American female with megaloblastic anemia and cobalamin deficiency, who inherited the variant from a heterozygote mother (Yassin, 2004). This variant was further observed in three patients of African descent, who were diagnosed with juvenile cobalamin deficiency, whereby parental haplotype analysis indicated a likely founder event of the deletion in the Sub-Saharan West-African lineage (Ament, 2009). Consistent with this study, the c.183_186delGAAT variant is identified on 17 out of 276,970 chromosomes, 14 from the African population, with an overall frequency of 0.006 percent listed in the Genome Aggregation Database (gnomAD). This variant is also reported to the ClinVar database with a pathogenic classification (Variation ID: 1743). Altogether the c.183_186delGAAT is pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 02, 2023 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 14576042, 22929189, 19036097, 22854512) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at